Overview

Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection

Status:
Unknown status
Trial end date:
2020-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy of a 14-day sequential therapy for the rescue treatment of refractory Helicobacter pylori infection, and whether it is safe while maintaining an ideal eradication rates.
Phase:
Phase 4
Details
Lead Sponsor:
Shandong University
Treatments:
Amoxicillin
Bismuth
Esomeprazole
Furazolidone
Pectin
Rabeprazole
Tetracycline